Skip to Content

a 135 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint a 135 is Blue / Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Zydus Pharmaceuticals.

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for a 135

Fenofibric acid delayed-release 135 mg a 135
Fenofibric acid delayed-release 135 mg a 135
Fenofibric acid delayed-release 135 mg a 135
Fenofibric acid delayed-release 135 mg a 135
Fenofibric acid delayed-release 135 mg a 135

Fenofibric Acid Delayed-Release

Imprint
a 135
Strength
135 mg
Color
Blue / Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals

Labelers / Repackagers

NDC CodeLabeler / Repackager
68382-0078 Zydus Pharmaceuticals (USA) Inc.
00074-9189 Abbott Laboratories
00115-1460 Global Pharmaceuticals
54868-5986 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "a 135"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.